Clinical trial
Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic…
NCT00123149 · Ortho Biotech Products, L.P., Industry · Withdrawn
Key facts
| NCT number | NCT00123149 |
|---|---|
| Title | Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis |
| Official title | An Open-Label (OL) Extension Study to Assess Safety of PROCRIT (Epoetin Alfa) in Patients With Anemia of Chronic Disease (ACD) Due to Rheumatoid Arthritis (RA) |
| Lead sponsor | Ortho Biotech Products, L.P., Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Epoetin alfa |
| Enrollment | 0 |
| Completion | Oct 1, 2007 |
| First posted | Jul 22, 2005 |
| Last update posted | Sep 20, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: